MADRIGAL PHARMACEUTICALS, INC. (MDGL) /
The revenue of MADRIGAL PHARMACEUTICALS, INC. over the past 10 years
Chart MADRIGAL PHARMACEUTICALS, INC.: revenue, fiscal 2016–2025 Open the chart →MADRIGAL PHARMACEUTICALS, INC. reported revenue of $958.4M in fiscal 2025, the latest fiscal year on file. In fiscal 2019 it was $0. Year over year, revenue rose twice. The largest one-year move was in fiscal 2025: up 432%, from $180.13M to $958.4M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $958.4M |
| 2024ended Dec 31, 2024 | $180.13M |
| 2023ended Dec 31, 2023 | $0 |
| 2022ended Dec 31, 2022 | $0 |
| 2021ended Dec 31, 2021 | $0 |
| 2020ended Dec 31, 2020 | $0 |
| 2019ended Dec 31, 2019 | $0 |
| 2018ended Dec 31, 2018 | — |
| 2017ended Dec 31, 2017 | — |
| 2016ended Dec 31, 2016 | — |
Fiscal years as MADRIGAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MADRIGAL PHARMACEUTICALS, INC.
- The profitability of MADRIGAL PHARMACEUTICALS, INC.
- The cash flow of MADRIGAL PHARMACEUTICALS, INC.
- The debt of MADRIGAL PHARMACEUTICALS, INC.
- All of MADRIGAL PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- SITMSiTime Corporation
- SWKSSKYWORKS SOLUTIONS, INC.
- BSYBENTLEY SYSTEMS, INCORPORATED
- HCMHutchMED (China) LIMITED
- DTMDT Midstream, Inc.
Not investment advice. This page shows what MADRIGAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.